An announcement from Dimerix Limited ( (AU:DXB) ) is now available.
Dimerix Limited has announced the quotation of 3,474,780 fully paid ordinary securities on the ASX, following the exercise of options or conversion of convertible securities. This move is part of the company’s ongoing efforts to enhance its market presence and provide liquidity to its stakeholders, potentially impacting its operational capabilities and industry positioning.
More about Dimerix Limited
Dimerix Limited operates in the biotechnology industry, focusing on the development of innovative pharmaceutical products, particularly in the area of kidney disease treatment. The company is listed on the Australian Securities Exchange (ASX) under the code DXB.
Average Trading Volume: 2,773,510
Technical Sentiment Signal: Buy
Current Market Cap: A$389.2M
See more data about DXB stock on TipRanks’ Stock Analysis page.